drugset / Trial / NCT01004705

A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Low Density Lipoprotein (LDL) Cholesterol

NCT01004705

Phase 2 Terminated 36 enrolled Ferrer Internacional S.A.
RandomizedCrossoverOpen-labelPrevention

Summary

This study evaluates the effect on LDL cholesterol of the 3 drugs given together in the cardiovascular fixed dose combination pill (acetylsalicylic acid, simvastatin, and ramipril) as compared to the effect on LDL cholesterol of simvastatin given alone. Approximately 76 subjects will be screened, 60 randomized in order about 52 subjects to finish the study.

Timeline

Start
2009-09
Primary completion
2011-03
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 100 mg Oral
Subject Ramipril Small molecule 5 mg Oral
Subject Ramipril Small molecule 10 mg Oral
Comparator Simvastatin Small molecule 40 mg Oral